Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
<h4>Objectives</h4>Useful indices to determine whether to reduce the dose of 5-aminosalicylic acid (5-ASA) in patients with ulcerative colitis (UC) during remission remain unclear. We aimed to analyze the rate and risk factors of relapse after reducing the dose of oral 5-ASA used for mai...
Guardado en:
Autores principales: | Akira Madarame, Masakatsu Fukuzawa, Yoshiya Yamauchi, Shin Kono, Akihiko Sugimoto, Hayato Yamaguchi, Takashi Morise, Yohei Koyama, Kumiko Uchida, Maya Suguro, Taisuke Matsumoto, Kagawa Yasuyuki, Takashi Kawai, Takao Itoi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4de879a84bbe452e9d62940bd4d5bb4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021) -
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi D, et al.
Publicado: (2017) -
Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
por: Leelahanaj T, et al.
Publicado: (2013) -
Adults with Crohn’s disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission
por: Lisa Dowling, et al.
Publicado: (2021) -
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
por: Kazuhiko Uchiyama, et al.
Publicado: (2014)